ZURICH/GDANSK, Dec 13(Reuters) - Here are some of the
main factors that may affect Swiss stocks on Friday:
GALDERMA GROUP AG GALD.S
The European Medicines Agency (EMA)’s Committee for
Medicinal Products for Human Use (CHMP) recommends approval of
the company's nemolizumab.
MOBILEZONE HOLDING AG MOZN.S
The company expects full-year EBIT margin to decrease from
4.2% to between 3.1-3.3%.
SWISS RE AG SRENH.S
To hold its management dialogue 2024.
ECONOMY
No major Swiss economic data scheduled.
(Reporting by Zurich newsroom and Gdansk newsroom)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))